Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine

References

• Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., & Samet, J. H. (2011). Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Archives of Internal Medicine, 171(5), 425–431.
   PubMedGoogle Scholar
• Ball, J. C., Shaffer, J. W., & Nurco, D. N. (1983). The day-to-day criminality of heroin addicts in Baltimore—A study in the continuity of offence rates. Drug and Alcohol Dependence, 12(2), 119–142.
   PubMed Web of Science ®Google Scholar
• Bell, J., Mattick, R., Hay, A., & Hall, J..C..W. (1997). Methadone maintenance and drug-related crime. Journal of Substance Abuse, 9, 15–25.
   PubMedGoogle Scholar
• Brooner, R. K., Kidorf, M. S., King, V. L., Stoller, K. B., Peirce, J. M., Bigelow, G. E., & Kolodner, K. (2004). Behavioral contingencies improve counseling attendance in an adaptive treatment model. Journal of Substance Abuse Treatment, 27(3), 223–232.
   PubMed Web of Science ®Google Scholar
• Bukten, A., Skurtveit, S., Gossop, M., Waal, H., Stangeland, P., Havnes, I., & Clausen, T. (2011). Engagement with opioid maintenance treatment and reductions in crime: A longitudinal national cohort study. Addiction, 107(2), 393–399.
   PubMed Web of Science ®Google Scholar
• Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: improving public health and safety. Journal of the American Medical Association, 301(2), 183–190.
   Web of Science ®Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., … Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1–53.
   PubMed Web of Science ®Google Scholar
• Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction 100(6), 820–828.
   PubMed Web of Science ®Google Scholar
• Fazel, S., Bains, P., & Doll, H. (2006). Substance abuse and dependence in prisoners: A systematic review. Addiction, 101(2), 181–191.
   PubMed Web of Science ®Google Scholar
• French, M. T., McGreary, K. A., Chitwood, D. D., McCoy, C. B., Inciardi, J. A., & McBride, D. (2000). Chronic drug use and crime. Substance Abuse 21(2), 95–109.
   PubMedGoogle Scholar
• Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., … Buprenorphine/Naloxone Collaborative Study Group. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349(10), 949–958.
   PubMed Web of Science ®Google Scholar
• Gastfriend, D. R., & McLellan, A. T. (1997). Treatment matching. Theoretical basis and practical implications. Medical Clinics of North America, 81(4), 945–966.
   PubMed Web of Science ®Google Scholar
• Genberg, B. L., Gillespie, M., Schuster, C. R., Johanson, C. E., Astemborski, J., Kirk, G. D., … Mehta, S. H. (2013). Prevalence and correlates of street-obtained buprenorphine among current and former injectors in Baltimore, Maryland. Addictive Behaviors, 38(12), 2868–2873.
   PubMed Web of Science ®Google Scholar
• Gryczynski, J., Jaffe, J. H., Schwartz, R. P., Dusek, K. A., Gugsa, N., Monroe, C. L., … Mitchell, S. G. (2013). Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. American Journal of Addiction. 22(3), 285–291.
   PubMed Web of Science ®Google Scholar
• Hakansson, A, & Berglund, M. (2012). Risk factors for criminal recidivism – A prospective follow-up study in prisoners with substance abuse. BMC Psychiatry, 12, 111.
   PubMed Web of Science ®Google Scholar
• Harris, E. E., Jacapraro, J. S., & Rastegar, D. A. (2012). Criminal charges prior to after initiation of office-based buprenorphine treatment. Substance Abuse Treatment Prevention and Policy, 7, 10.
   PubMed Web of Science ®Google Scholar
• Harris, E. E., Jacapraro, J. S., & Rastegar, D. A. (2013). Prior criminal charges and outcomes among individuals initiating office-based buprenorphine treatment. Health and Justice, 1, 2.
   Google Scholar
• Hubbard, R. L., Rachal, J. V., Craddock, S. G., & Cavanaugh, E. R. (1984). Treatment Outcome Prospective Study (TOPS): Client characteristics and behaviors before, during, and after treatment. In F. M. Tims & Ludford, J. P. (Eds.), Drug abuse treatment evaluation: strategies, progress, and prospects (pp. 42–68). ( NIDA Research Monograph 51). Rockville, MD: U.S. Department of Health and Human Services.
   Google Scholar
• Kelly, S. M., Brown, B. S., Katz, E. C., O'Grady, K. E., Mitchell, S. G., King, S., & Schwartz, R. P. (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients. American Journal of Drug and Alcohol Abuse 38(3), 233–238.
   PubMed Web of Science ®Google Scholar
• Kidorf, M., King, V. L., Neufeld, K., Stoller, K. B., Peirce, J., & Brooner, R. K. (2005). Involving significant others in the care of patients receiving methadone. Journal of Substance Abuse Treatment, 29(1), 19–27.
   PubMed Web of Science ®Google Scholar
• King, V. L., & Brooner, R. K. (2008). Improving treatment engagement in opioid-dependent outpatients with a motivated stepped-care adaptive treatment model. The Joint Commission Journal on Quality and Patient Safety, 34(4), 209–213.
   PubMedGoogle Scholar
• Larney, S., Toson, B., & Dolan, K. (2012). Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. Addiction, 107(2), 372–380.
   PubMed Web of Science ®Google Scholar
• Lobemann, R., & Verthein, U. (2009). Explaining effectiveness of heroin-assisted treatment on crime reductions. Law and Human Behavior, 33(1), 83–95.
   PubMed Web of Science ®Google Scholar
• Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug and Alcohol Dependence, 99(1–3), 222–230.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003). Burpenorphine versus methadone therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98(4):441–452.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Burpenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2, CD002207.
   Google Scholar
• Mitchell, S. G., Gryczynski, J., Kelly, S. M., O'Grady, K. E., Jaffe, J. H., Olsen, Y. K., & Schwartz, R. P. (2014). Treatment outcomes of African American buprenorphine patients by parole and probation status. Journal of Drug Issues, 44(1), 69–82.
   PubMed Web of Science ®Google Scholar
• Murphy, S., & McKay, J. R. (2004). Adaptive treatment strategies: An emerging approach for improving treatment effectiveness. Clinical Science, newsletter of the American Psychological Association Division 12, section III: The Society for the Science of Clinical Psychology (newsletter), (Winter-Spring), 7–13.
   Google Scholar
• Schwartz, R. P., Highfield, D. A., Jaffe, J. H., Brady, J. V., Butler, C. B., Rouse, C. O., … Battjes, R. J. (2006). A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry, 63(1), 102–109.
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Jaffe, J. H., O'Grady, K. E., Kinlock, T. W., Gordon, M. S., Kelly, S. M., … Ahmed, A. (2009). Interim methadone treatment: impact on arrests. Drug and Alcohol Dependence 103(3), 148–154.
   PubMed Web of Science ®Google Scholar
• Sobell, M. B., & Sobell, L. C. (2000). Stepped care as a heuristic approach to the treatment of alcohol problems. Journal of Consult Clinical Psychology, 68(4), 573–579.
   PubMed Web of Science ®Google Scholar
• Soeffing, J. M., Martin, L. D., Fingerhood, M. I., Jasinski, D. R., & Rastegar, D. A. (2009). Buprenorphine maintenance in a primary care setting: outcomes at one year. Journal of Substance Abuse Treatment, 37(4), 426–430.
   PubMed Web of Science ®Google Scholar
• Stewart, D., Gossop, M., Mardsen, J., & Rolfe, A. (2000). Drug misuse and acquisitive crime among clients recruited to the National Treatment Outcome Research Study (NTORS). Criminal Behavior and Mental Health, 10(1), 10–20.
   Google Scholar
• Sullivan, L. E., Chawarski, M., O'Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2005). The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment? Drug and Alcohol Dependence, 79(1), 113–116.
   PubMed Web of Science ®Google Scholar
• Wang, E. A., Moore, B. A., Sullivan, L. E., & Fiellin, D. A. (2010). Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. Journal of General Internal Medicine, 25(7), 670–67.
   PubMed Web of Science ®Google Scholar